InstalabSIBO Breath Test (Glucose, 3 Hour)
Should you take a SIBO Breath Test (Glucose, 3 Hour) test?
This test is most useful if any of these apply to you.
3 biomarkers included
- Peak Hydrogen (H₂) - GlucoseShows the size of the hydrogen response across the full glucose challenge. It helps separate an early small intestinal bacterial overgrowth (SIBO) pattern from a later colon pattern.Why it mattersA high early peak supports SIBO; a high late peak can point to fast gut movement or colon fermentation.
- Peak Methane (CH₄) - GlucoseTracks methane made by methanogens. These methane-making microbes are not bacteria. At least 10 parts per million supports intestinal methanogen overgrowth (IMO).Why it mattersHigh methane is associated with constipation and may call for a methane-focused prescription plan.
- H₂ Rise by 90 minutes - GlucoseCore hydrogen criterion: a rise of at least 20 parts per million from baseline by 90 minutes supports glucose being broken down too early in the small bowel.Why it mattersAn early hydrogen rise points to bacteria breaking down glucose high in the small intestine.
About SIBO Breath Test (Glucose, 3 Hour)
Bloating, gas, and bowel habits that no diet seems to fix sometimes trace back to too many microbes in the small intestine. That part of the gut is usually much less crowded than the colon. When microbes grow there in excess, they can break down sugar too early, and the gas they make is part of what you feel.
This is a glucose breath test. You drink a measured glucose solution and breathe into a collector over three hours. Small intestinal bacterial overgrowth is usually shortened to SIBO. The test does not see microbes directly; it reads the gases they leave behind.
What This Panel Reveals
Human cells don't make hydrogen or methane. Gut microbes do. So the test asks a simple question: after glucose, do your breath gases behave like sugar is being broken down too early?
Hydrogen usually points to bacteria breaking down glucose. Methane points to methane-making microbes, now called intestinal methanogen overgrowth. Methanogens are archaea. Archaea are a separate group of microbes, not bacteria. In human studies, methane-positive breath tests are associated with constipation and slower gut movement, though the strength of that link is still debated.
The timing marker is about place. The lab reports gas in parts per million. Glucose is usually absorbed high in the small intestine, so a hydrogen rise of at least 20 parts per million within 90 minutes supports microbes breaking down glucose early in the small bowel. A later peak is less clean, because the signal may come from the colon.
How to Read Your Results Together
A positive hydrogen pattern is a rise of at least 20 parts per million by 90 minutes. Methane is different: at least 10 parts per million at any point supports intestinal methanogen overgrowth (IMO), even if hydrogen stays low. Together these results show the gas pattern, not a perfect map of where every microbe lives.
| Pattern | What It Suggests |
|---|---|
| Hydrogen rises by 90 minutes, methane low | Hydrogen-type SIBO. This pattern often goes with gas, bloating, and diarrhea. |
| Methane high, hydrogen low | Intestinal methanogen overgrowth. Methane-making microbes may be the main signal, often reported alongside constipation. |
| Both hydrogen and methane high | Mixed SIBO and methane-making microbe overgrowth. Treatment planning often has to account for both signals. |
| Both flat, no early rise | Overgrowth is not supported by this glucose test. Lower-small-bowel overgrowth or hydrogen-low patterns can still be missed. |
The methane label matters because the main methane maker in many positive tests, Methanobrevibacter smithii, is not a bacterium. Methane-positive cases may need a different prescription plan than hydrogen-positive SIBO, but the evidence for exact drug choices is thinner than the evidence for the breath-test cutoffs.
What to Do With Your Results
A positive result is a starting point for treatment, often with a prescription antibiotic such as rifaximin. Methane-positive results may lead to combination therapy. Rifaximin is not an FDA-approved treatment for SIBO, so it is used off-label; because treatment is prescription-based, use the result with a clinician who treats gut disorders. A negative result doesn't close the case when symptoms still fit SIBO, because glucose testing can miss overgrowth lower in the small bowel.
Relapse is common enough that repeat testing can be useful. In one follow-up study after rifaximin treatment, about 1 in 8 people tested positive again at 3 months and more than 4 in 10 by 9 months. Testing again after treatment is most useful when symptoms persist or return.
When Results Can Be Misleading
What you eat before the test can shift the result. The day-before diet is intentionally plain: low fiber and low in foods gut microbes easily break down. Studies show stricter prep lowers baseline hydrogen and methane and reduces the number of positive tests. Recent antibiotics can suppress gas-making microbes and hide overgrowth.
Speed is the main trap. If glucose reaches the colon early, colon microbes can make gas soon enough to look like SIBO. In one study that tracked the glucose with imaging, 48% of abnormal glucose breath tests were explained by early colon gas-making, especially after upper gut surgery. A result that clashes with your symptoms is worth confirming before you base treatment on it.